Optimism On ICDs: St. Jude And Boston Scientific Exceed Expectations
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical reported strong cardiac rhythm management results in the second quarter and said it picked up market share, but struggling competitor Boston Scientific refused to recoil, announcing U.S. ICD sales losses that were about half what was expected